Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Muller

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Infection Control and Hospital Epidemiology|November 17, 2021
Validation and implementation of group electronic hand hygiene monitoring across twenty-four critical care unitsJerome A Leis, Maryam Obaidallah, Victoria Williams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillanceStefan P Kuster, Wallis Rudnick, Altynay Shigayeva, et al.
Frontiers in Public Health|August 27, 2024
Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort studyPhyumar Soe, Manish Sadarangani, Monika Naus, et al.
Vaccine|May 7, 2024
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety NetworkPhyumar Soe, Hubert Wong, Monika Naus, et al.
The Lancet. Infectious Diseases|August 14, 2022
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort studyManish Sadarangani, Phyumar Soe, Hennady P Shulha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2022
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety NetworkJulie A Bettinger, Michael A Irvine, Hennady P Shulha, et al.
Vaccine|October 16, 2024
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) studyKarina A Top, Hennady P Shulha, Matthew P Muller, et al.
Vaccine|May 7, 2026
mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety networkMatthew P Muller, Phyumar Soe, Hennady P Shulha, et al.
Lancet Regional Health. Americas|December 11, 2024
mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort studyPhyumar Soe, Otto G Vanderkooi, Manish Sadarangani, et al.
Epidemiology and Infection|June 23, 2025
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023Brenda L Coleman, Nicole M Robertson, Robyn A Harrison, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Infection Control and Hospital Epidemiology|November 17, 2021
Validation and implementation of group electronic hand hygiene monitoring across twenty-four critical care unitsJerome A Leis, Maryam Obaidallah, Victoria Williams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillanceStefan P Kuster, Wallis Rudnick, Altynay Shigayeva, et al.
Frontiers in Public Health|August 27, 2024
Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort studyPhyumar Soe, Manish Sadarangani, Monika Naus, et al.
Vaccine|May 7, 2024
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety NetworkPhyumar Soe, Hubert Wong, Monika Naus, et al.
The Lancet. Infectious Diseases|August 14, 2022
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort studyManish Sadarangani, Phyumar Soe, Hennady P Shulha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2022
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety NetworkJulie A Bettinger, Michael A Irvine, Hennady P Shulha, et al.
Vaccine|October 16, 2024
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) studyKarina A Top, Hennady P Shulha, Matthew P Muller, et al.
Vaccine|May 7, 2026
mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety networkMatthew P Muller, Phyumar Soe, Hennady P Shulha, et al.
Lancet Regional Health. Americas|December 11, 2024
mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort studyPhyumar Soe, Otto G Vanderkooi, Manish Sadarangani, et al.
Epidemiology and Infection|June 23, 2025
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023Brenda L Coleman, Nicole M Robertson, Robyn A Harrison, et al.
Pageof 9